Allan Walkey to Anticoagulants
This is a "connection" page, showing publications Allan Walkey has written about Anticoagulants.
Connection Strength
1.287
-
Li S, Lip GYH, Ko D, Walkey A. Anticoagulation for Secondary Atrial Fibrillation. N Engl J Med. 2024 Apr 04; 390(13):1237-1240.
Score: 0.666
-
Walkey AJ, Quinn EK, Winter MR, McManus DD, Benjamin EJ. Practice Patterns and Outcomes Associated With Use of Anticoagulation Among Patients With Atrial Fibrillation During Sepsis. JAMA Cardiol. 2016 09 01; 1(6):682-90.
Score: 0.394
-
Walkey AJ, Myers LC, Thai KK, Kipnis P, Desai M, Go AS, Lu Y, Clancy H, Devis Y, Neugebauer R, Liu VX. Practice Patterns and Outcomes Associated With Anticoagulation Use Following Sepsis Hospitalizations With New-Onset Atrial Fibrillation. Circ Cardiovasc Qual Outcomes. 2023 03; 16(3):e009494.
Score: 0.154
-
Ko D, Lin KJ, Bessette LG, Lee SB, Walkey AJ, Cheng S, Kim E, Glynn RJ, Kim DH. Trends in Use of Oral Anticoagulants in Older Adults With Newly Diagnosed Atrial Fibrillation, 2010-2020. JAMA Netw Open. 2022 11 01; 5(11):e2242964.
Score: 0.038
-
Ko D, Saleeba C, Sadiq H, Crawford S, Paul T, Shi Q, Wang Z, Benjamin EJ, Walkey AJ, Lubitz SA, Kapoor A, McManus D. Secondary Precipitants of Atrial Fibrillation and Anticoagulation Therapy. J Am Heart Assoc. 2021 11 02; 10(21):e021746.
Score: 0.035